Liz Selby, Country Lead for Sanofi Australia and New Zealand, said, "Despite progress in relapsing remitting MS treatments, there remains a significant burden on people with nrSPMS who have limited treatment options to manage their disease progression." …
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News